Today: 9 June 2026
CRH PLC Stock After Hours Today (Dec. 22, 2025): S&P 500 Debut, Fresh Buyback Disclosure, and What to Know Before Tuesday’s Market Open
23 December 2025
5 mins read

CRH PLC Stock After Hours Today (Dec. 22, 2025): S&P 500 Debut, Fresh Buyback Disclosure, and What to Know Before Tuesday’s Market Open

CRH PLC (NYSE: CRH) ended Monday’s session with a steady, index-driven tone as the building materials giant completed its first day as an S&P 500 constituent and investors digested a new “Transaction in Own Shares” buyback update released earlier today. Heading into Tuesday’s open (Dec. 23, 2025), the setup is less about a single headline catalyst and more about liquidity, index flows, and macro data risk in a holiday-shortened week.

CRH stock price after the bell: where shares closed and what after-hours is saying

CRH shares closed at $126.22 at 4:00 p.m. ET, up $1.80 (+1.45%) on the day. The stock traded between $124.34 and $126.66 during the regular session, with volume around 7.7 million shares—notably active for a holiday week Monday.

In after-hours trading, CRH was flat at $126.22 as of the most recently posted extended-hours update (no meaningful post-close move indicated).

Context that matters for Tuesday: CRH is now trading just below its 52-week high of $128.95 (with a 52-week range of $76.75–$128.95), putting the stock near a level where short-term profit-taking or momentum follow-through can swing quickly—especially in thin holiday liquidity.

The big structural catalyst today: CRH’s first day in the S&P 500

Today (Monday, Dec. 22, 2025) wasn’t just another trading day for CRH: it marked the company’s effective inclusion in the S&P 500 as part of the quarterly rebalance.

  • S&P Dow Jones Indices previously announced that CRH would be added to the S&P 500 (Materials sector) effective prior to the open of trading on Dec. 22, 2025, aligning with the quarterly rebalance.
  • CRH itself confirmed it was selected to join the index and that inclusion would be effective before today’s open.

Why this matters after the bell: S&P 500 inclusion often brings mechanical demand from index-tracking funds and mandates that must own S&P 500 members. Some of that repositioning can spill into the closing auction or be spread over multiple sessions depending on how portfolios execute and how much trading they want to concentrate in one day.

What to watch Tuesday: whether today’s inclusion-related activity is “done” or whether there’s still follow-on rebalancing as portfolios tidy up exposures in the next one to three sessions—particularly in a week when trading desks are frequently lighter staffed.

Today’s CRH-specific news: a fresh buyback disclosure (dated Dec. 22)

CRH released a UK regulatory announcement today titled “Transaction in Own Shares” describing additional repurchases under its ongoing program.

Key details from today’s notice:

  • CRH said it acquired 31,000 ordinary shares on Dec. 19, 2025 on the NYSE (trading venue: XNYS).
  • It reported a daily volume-weighted average price of $127.3702, with a daily high of $127.91 and daily low of $126.54.
  • CRH stated the repurchases form part of its plan to buy back up to $300 million of ordinary shares through Feb. 17, 2026, referencing the company’s previously announced program.
  • After settlement and cancellation, CRH said it would have 669,121,102 ordinary shares in issue (excluding treasury) and 38,043,540 shares held in treasury (5.380% of issued ordinary share capital), noting treasury shares have no voting rights.

How investors typically interpret this: This kind of disclosure is usually not a “price mover” by itself—especially at a modest size versus daily trading volume—but it reinforces a message of ongoing capital return and share count management. In a tape dominated by macro and flows, these buyback updates can still matter at the margins.

Broader market backdrop: materials strength, holiday liquidity, and why it matters for CRH

CRH sits in the Materials sleeve of the S&P 500 now, and Monday’s broader tape was supportive. Reuters described U.S. markets starting the holiday-shortened week higher, with materials and energy among the leading sectors, while also flagging expectations for light trading due to the Christmas holiday.

The Associated Press also reported broad gains in major indexes to open the holiday week.

Translation for CRH traders: even if there’s no CRH-only headline, sector leadership combined with index inclusion can create a tailwind—while holiday conditions can amplify moves both up and down.

Analyst forecasts and price targets: what the Street expects (and the range of outcomes)

Even with today’s index milestone, the bigger debate for CRH remains valuation versus its infrastructure and construction-cycle exposure. Across widely followed aggregator datasets, the Street’s stance is generally constructive—though the exact consensus varies by provider.

Here are the most commonly referenced snapshots available as of today:

  • StockAnalysis (consensus view): 14 analysts show a consensus rating of “Strong Buy” with an average price target of $131.71 (about +4% from current levels), with targets ranging from $114 to $160. StockAnalysis
  • Fintel (broader compiled targets): average one-year price target listed at $137.01, with a wide forecast range from $93.05 to $168.00 (and an “estimated share price by December 21, 2026” framing). Fintel
  • MarketWatch snapshot (search result data): shows an average target around $139.54, with a high near $164 and low near $112, and a “Buy” recommendation count. MarketWatch

How to use these numbers going into Tuesday:

  1. Treat consensus targets as a sentiment thermometer, not a promise.
  2. The spread between low and high targets is a reminder that CRH is still a cycle-sensitive business: rates, public infrastructure timing, private nonresidential demand, and materials pricing all drive “reasonable” differences in valuation models.
  3. The most practical takeaway for the next session is whether the stock holds above key nearby reference points: today’s low ($124.34) and the prior close ($124.42) are immediate, visible levels traders will watch.

What to know before the market opens Tuesday, Dec. 23, 2025

The overnight checklist for CRH is a mix of macro triggers and micro mechanics:

1) Big U.S. economic data risk is front-loaded Tuesday morning

Multiple calendars and market previews point to high-impact U.S. data releases on Tuesday, including:

  • Q3 GDP (delayed report) and durable-goods orders scheduled for 8:30 a.m. ET (MarketWatch calendar listing).
  • Market previews also highlight a cluster of releases Tuesday that can move yields and cyclicals, including GDP and other activity/inflation-adjacent reports.

Why CRH cares: building materials and infrastructure-linked equities can be highly sensitive to rate expectations. If data pushes Treasury yields meaningfully up or down, it can change the “multiple investors are willing to pay” for a large-cap cyclical even when the company’s fundamentals didn’t change overnight.

2) Expect holiday trading conditions—and know the schedule

This week’s market structure matters:

  • The NYSE notes an early close at 1:00 p.m. ET on Wednesday, Dec. 24, 2025, and markets are closed for Christmas.
  • Reuters also pointed to the holiday-shortened week dynamic and lighter participation expectations.

Why this matters before Tuesday’s open: when liquidity is thinner, price gaps can be larger, and “normal” technical levels can break more easily on less volume.

3) Watch for continued S&P 500-related positioning

Even though inclusion became effective before today’s open, portfolio implementation can lag—especially for active funds that rebalance more gradually or for strategies that wait for specific liquidity windows.

Signs to watch Tuesday morning:

  • unusually high premarket prints or a strong opening auction relative to typical days,
  • heavy volume near the close again,
  • CRH’s intraday behavior versus the Materials sector (now that it is formally part of that index ecosystem).

4) Keep an eye on buyback disclosures

CRH has been issuing frequent “Transaction in Own Shares” notices as part of the current program. Today’s announcement reinforces that the company is actively executing the buyback and cancelling shares. Business Wire+1

For traders, this matters less because of the size of any single day’s repurchase and more because:

  • it can provide a steady bid over time,
  • it supports the “capital return” narrative that tends to matter more when macro volatility rises.

CRH fundamentals in one paragraph (why the market still cares beyond today’s flows)

CRH describes itself as a leading provider of building materials, and it has intentionally aligned its listing strategy with its business mix—highlighting that it is listed on both NYSE and LSE, with NYSE as the primary listing venue since Sept. 25, 2023.

For longer-horizon investors, the thesis usually centers on CRH’s scale in North American construction materials, its exposure to public infrastructure and large private projects, disciplined capital allocation, and shareholder returns through dividends and buybacks—balanced against the reality that construction cycles can cool quickly if financing conditions tighten.

Bottom line for Tuesday’s open

CRH stock closed Monday at $126.22 and stayed flat after-hours, capping a day where the company’s S&P 500 inclusion became effective and investors absorbed a fresh buyback transaction disclosure.

The most important “before the bell” variables for Tuesday are:

  • 8:30 a.m. ET macro data (GDP, durable goods) and the interest-rate reaction,
  • whether any post-inclusion index/ETF flows continue into a second session,
  • and holiday-week liquidity conditions that can magnify moves.

Stock Market Today

  • Docebo (TSX:DCBO) Valuation Story Shifts Amid Revised Earnings Guidance
    June 9, 2026, 10:40 AM EDT. Docebo's fair value remains at CA$35.97 despite updated financial models, reflecting a recalibration of valuation assumptions. Analysts highlight contrasting bullish views, citing a clear growth story backed by recent revenue guidance raising full-year 2026 estimates to US$271-275 million, against bearish concerns over limited analyst coverage and potential risks. The e-learning software provider forecast revenue of approximately US$65.4-65.6 million for Q1 2026, and US$66.7-66.9 million for Q2. At its Inspire 2026 event, Docebo unveiled a next-generation learning platform and key product updates, signaling strategic progress. Investors should monitor shifting assumptions and sector context amid evolving market narratives.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Bitcoin Price Today (Dec. 22, 2025, 5:01 p.m. ET): BTC Trades Near $88K as JPMorgan Crypto Plans, ETF Flows, and Strategy’s Pause Shape the Outlook
Previous Story

Bitcoin Price Today (Dec. 22, 2025, 5:01 p.m. ET): BTC Trades Near $88K as JPMorgan Crypto Plans, ETF Flows, and Strategy’s Pause Shape the Outlook

Salesforce Stock (CRM) After Hours on Dec. 22, 2025: Shares Hold Near $265 After Evercore’s 2026 Top-Pick Call — What to Know Before the Dec. 23 Market Open
Next Story

Salesforce Stock (CRM) After Hours on Dec. 22, 2025: Shares Hold Near $265 After Evercore’s 2026 Top-Pick Call — What to Know Before the Dec. 23 Market Open

Go toTop